SurgePays (SURG) analyst forecast and price target
Analyst forecast
Consensus of 1 analyst rating
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Ascendiant Capital | Maintained | Buy | $3.50 from $5.00 | Jun 10, 2026 |
| Ascendiant Capital | Maintained | Buy | $5.00 from $9.75 | Apr 17, 2026 |
| Ascendiant Capital | Maintained | Buy | $9.75 from $9.50 | Dec 22, 2025 |
| Ascendiant Capital | Maintained | Buy | $9.50 from $9.00 | Oct 3, 2025 |
| Ascendiant Capital | Maintained | Buy | $9.00 from $8.75 | Jun 16, 2025 |
| Ascendiant Capital | Maintained | Buy | $8.75 from $8.50 | Apr 22, 2025 |
| Ascendiant Capital | Maintained | Buy | $8.50 from $9.00 | Dec 16, 2024 |
| Ascendiant Capital | Maintained | Buy | $9.00 from $9.50 | Sep 11, 2024 |
| Ascendiant Capital | Maintained | Buy | $9.50 from $10.00 | Jun 6, 2024 |
| Ascendiant Capital | Maintained | Buy | $10.00 from $11.50 | Apr 1, 2024 |
| Maxim Group | Downgraded | Buy → Hold | — | Mar 13, 2024 |
Frequently asked questions
Is SURG a buy, sell, or hold?
Analysts covering SurgePays currently average a Buy rating: 1 buy, 0 hold and 0 sell, from 1 analyst. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on SURG?
On Jun 10, 2026, Ascendiant Capital maintained SurgePays at Buy with a price target of $3.50.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.